Gastric Cancer

• CLINICAL_TRIALS trial_result · 2020-03-11
  Clinical Trial Update: Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors [Phase 1]

  This Phase 1 open-label dose-finding study evaluated the safety and pharmacokinetics of FPA144 in patients with advanced solid tumors, inclu…

• CLINICAL_TRIALS trial_result · 2020-03-03
  Clinical Trial Update: Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric Cancer [Phase 3]

  Phase 3 clinical trial update on lymph node dissection (14v) in clinically advanced gastric cancer (T3N+, T4N+).

• CLINICAL_TRIALS trial_result · 2020-03-02
  Clinical Trial Update: Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer [Phase 3]

  Phase 3 trial evaluating the DOS regimen (Docetaxel, Oxaliplatin, S-1) as neoadjuvant chemotherapy for advanced gastric cancer; results post…

• CLINICAL_TRIALS trial_result · 2020-02-27
  Clinical Trial Update: Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer [Phase 1, Phase 2]

  Phase 1/2 clinical trial evaluating albumin-paclitaxel combined with apatinib and camrelizumab in advanced gastric cancer.

• CLINICAL_TRIALS trial_result · 2020-02-17
  Clinical Trial Update: A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]

  Phase Ib/2 trial evaluating Fruquintinib in combination with Paclitaxel for advanced gastric cancer has been completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-02-13
  Clinical Trial Update: Perioperative Chemotherapy for Potentially Resectable Gastric Cancer [Phase 2, Phase 3]

  Clinical trial update on perioperative chemotherapy for potentially resectable gastric cancer spanning Phase 2 and Phase 3 completed.

• CLINICAL_TRIALS trial_result · 2020-02-11
  Clinical Trial Update: Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 2]

  Phase 2 trial evaluating conversion therapy with sintilimab plus CAPOX in unresectable locally advanced or limited metastatic stomach/EGJ ad…

• CLINICAL_TRIALS trial_result · 2020-02-10
  Clinical Trial Update: The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. [Phase 2]

  A Phase 2 clinical trial evaluating sintilimab in combination with Xelox as neoadjuvant therapy for resectable locally advanced gastric or g…

• CLINICAL_TRIALS trial_result · 2020-02-10
  Clinical Trial Update: Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) [Phase 2]

  Phase 2 trial evaluating preoperative chemotherapy and chemoradiotherapy for adenocarcinoma of the stomach and gastroesophageal junction has…

• CLINICAL_TRIALS trial_result · 2020-02-07
  Clinical Trial Update: A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors [Phase 1]

  Phase 1 trial evaluating PEGPH20 with pembrolizumab in hyaluronan-high tumors including non-small cell lung cancer and gastric cancer; study…

• CLINICAL_TRIALS trial_result · 2020-02-06
  Clinical Trial Update: Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric Cancer [Phase 2]

  Phase 2 trial update investigating camrelizumab combined with apatinib, paclitaxel-albumin, and S-1 for gastric cancer.

• CLINICAL_TRIALS trial_result · 2020-02-06
  Clinical Trial Update: Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer [Phase 2]

  Phase 2 clinical trial update evaluating neoadjuvant chemotherapy with paclitaxel-albumin and S-1 for advanced gastric cancer.

• CLINICAL_TRIALS trial_result · 2020-02-05
  Clinical Trial Update: Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer [Phase 2]

  Phase 2 trial update investigating apatinib combined with SOX as neoadjuvant therapy for locally advanced gastric cancer.

• CLINICAL_TRIALS trial_result · 2020-02-05
  Clinical Trial Update: Clinical Outcomes of Laparoscopic D1 Versus D2 Lymphadenectomy for Elderly Patients With Advanced Gastric Cancer [Phase 2]

  Phase 2 clinical trial update comparing laparoscopic D1 versus D2 lymphadenectomy for elderly patients with advanced gastric cancer.

• CLINICAL_TRIALS trial_result · 2020-01-29
  Clinical Trial Update: A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy [Phase 3]

  Phase 3 randomized, double-blind trial comparing paclitaxel with and without RAD001 in advanced gastric cancer after prior chemotherapy (com…

• CLINICAL_TRIALS trial_result · 2020-01-22
  Clinical Trial Update: Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer [Phase 2]

  Phase 2 trial update exploring the use of liquid biopsy to monitor neoadjuvant chemotherapy and surgical outcomes in gastric and gastro-oeso…

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS [Phase 3]

  Phase 3 trial comparing 3-weekly versus 5-weekly S-1 plus cisplatin in advanced gastric cancer has completed.

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer [Phase 2]

  Phase II study of ramucirumab in combination with chemotherapy for metastatic gastric/gastroesophageal junction cancer was terminated; resul…

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX [Phase 2]

  Phase 2 trial evaluating trastuzumab with XELOX in HER2-positive advanced gastric cancer has completed.

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1 [Phase 2]

  Phase 2 trial update for dovitinib in gastric cancer with FGFR2 amplification (GASDOVI-1) has completed.

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE [Phase 2]

  Phase 2 clinical trial investigating sorafenib in advanced and/or recurrent gastric adenocarcinoma (STARGATE) has completed.

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression [Phase 2]

  Phase 2 trial update of RAD001 in advanced gastric cancer after failure of first-line therapy.

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer [Phase 2]

  Phase 2 trial updating efficacy of a combination regimen (docetaxel, capecitabine, cisplatin, and bevacizumab) in unresectable advanced gast…

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP [Phase 1, Phase 2]

  Phase 1/2 study evaluating vorinostat plus capecitabine and cisplatin as first-line therapy for metastatic or recurrent gastric cancer has c…

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin [Phase 2]

  Phase 2 trial of biweekly FOLFIRI in advanced gastric cancer after failure of taxane, fluoropyrimidine, and cisplatin has completed.